0 Ratings

ID

13881

Description

New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC); ODM derived from: https://clinicaltrials.gov/show/NCT01482104

Link

https://clinicaltrials.gov/show/NCT01482104

Keywords

  1. 3/13/16 3/13/16 -
Uploaded on

March 13, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Skin Neoplasms NCT01482104

    Eligibility Skin Neoplasms NCT01482104

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    male/female above 18 years of age
    Description

    gender; age

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0079399
    UMLS CUI [2]
    C0001779
    written informed consent
    Description

    informed consent

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    1 or more primary histologically verified bcc, clinically assessed as of either superficial of nodular type
    Description

    Basal Cell Carcinoma

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0007117
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    pregnancy
    Description

    pregnancy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    breastfeeding
    Description

    breastfeeding

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0006147
    gorlin's syndrome
    Description

    gorlins syndrome

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0004779
    porphyria
    Description

    porphyria

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C3463940
    xeroderma pigmentosum
    Description

    xeroderma pigmentosum

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0043346
    history of arsenic exposure
    Description

    arsenic exposure

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0238690
    known allergy to mal
    Description

    hypersensitivity methyl 5-aminolevulinate

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C1134467
    concomitant treatment with immunosuppressive medication
    Description

    concomitant treatment immunosuppressive medication

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1707479
    UMLS CUI [1,2]
    C0021081
    physical or mental conditions that most likely will prevent patients attending follow-up sessions
    Description

    Compliance behavior Limited Comorbidity

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1321605
    UMLS CUI [1,2]
    C0439801
    UMLS CUI [1,3]
    C0009488

    Similar models

    Eligibility Skin Neoplasms NCT01482104

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    gender; age
    Item
    male/female above 18 years of age
    boolean
    C0079399 (UMLS CUI [1])
    C0001779 (UMLS CUI [2])
    informed consent
    Item
    written informed consent
    boolean
    C0021430 (UMLS CUI [1])
    Basal Cell Carcinoma
    Item
    1 or more primary histologically verified bcc, clinically assessed as of either superficial of nodular type
    boolean
    C0007117 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    pregnancy
    Item
    pregnancy
    boolean
    C0032961 (UMLS CUI [1])
    breastfeeding
    Item
    breastfeeding
    boolean
    C0006147 (UMLS CUI [1])
    gorlins syndrome
    Item
    gorlin's syndrome
    boolean
    C0004779 (UMLS CUI [1])
    porphyria
    Item
    porphyria
    boolean
    C3463940 (UMLS CUI [1])
    xeroderma pigmentosum
    Item
    xeroderma pigmentosum
    boolean
    C0043346 (UMLS CUI [1])
    arsenic exposure
    Item
    history of arsenic exposure
    boolean
    C0238690 (UMLS CUI [1])
    hypersensitivity methyl 5-aminolevulinate
    Item
    known allergy to mal
    boolean
    C0020517 (UMLS CUI [1,1])
    C1134467 (UMLS CUI [1,2])
    concomitant treatment immunosuppressive medication
    Item
    concomitant treatment with immunosuppressive medication
    boolean
    C1707479 (UMLS CUI [1,1])
    C0021081 (UMLS CUI [1,2])
    Compliance behavior Limited Comorbidity
    Item
    physical or mental conditions that most likely will prevent patients attending follow-up sessions
    boolean
    C1321605 (UMLS CUI [1,1])
    C0439801 (UMLS CUI [1,2])
    C0009488 (UMLS CUI [1,3])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial